The FTC first sought to challenge Illumina's acquisition of cancer detection company GRAIL in March 2021. Illumina announced in September 2020 that it would acquire GRAIL, a subsidiary it had previously spun off.
Roughly a year later, the company completed theFTC appeals ruling in case challenging Illumina's acquisition of GRAIL
Sverige Nyheter Nyheter
The Federal Trade Commission on Friday filed a notice of appeal in its case challenging Illumina's $7.1 billion acquisition of cancer detection company GRAIL.